{"id":"https://openalex.org/W7213588339","doi":"https://doi.org/10.64898/2026.09.12.751171","title":"Pan-B-Lineage Targeting with Adapter CAR-T Cells Controls Antigen-Heterogeneous Lymphoma","display_name":"Pan-B-Lineage Targeting with Adapter CAR-T Cells Controls Antigen-Heterogeneous Lymphoma","publication_year":2026,"publication_date":"2026-09-18","ids":{"openalex":"https://openalex.org/W7213588339","doi":"https://doi.org/10.64898/2026.09.12.751171"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.12.751171","doi":"https://doi.org/10.64898/2026.09.12.751171","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.12.751171","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/18/2026.09.12.751171.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/18/2026.09.12.751171.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093373441","display_name":"Simon Krost","orcid":"https://orcid.org/0009-0000-4257-4334","observed_orcids":["https://orcid.org/0009-0000-4257-4334"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]},{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]},{"id":"https://openalex.org/I4210117394","display_name":"Hopp Children's Cancer Center Heidelberg","ror":"https://ror.org/02cypar22","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210117394"]},{"id":"https://openalex.org/I4210125796","display_name":"University Children's Hospital T\u00fcbingen","ror":"https://ror.org/03esvmb28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118","https://openalex.org/I4210125796"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Simon Krost","raw_affiliation_strings":["Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany","Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany","Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Heidelberg, Germany","Hopp Children\u2019s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany"],"raw_orcid":"https://orcid.org/0009-0000-4257-4334","affiliations":[{"raw_affiliation_string":"Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529"]},{"raw_affiliation_string":"Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210125796"]},{"raw_affiliation_string":"Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Heidelberg, Germany","institution_ids":["https://openalex.org/I2802164966"]},{"raw_affiliation_string":"Hopp Children\u2019s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany","institution_ids":["https://openalex.org/I4210117394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072158833","display_name":"Anna\u2010Sophia Mast","orcid":"https://orcid.org/0009-0005-3356-5563","observed_orcids":["https://orcid.org/0009-0005-3356-5563"]},"institutions":[{"id":"https://openalex.org/I4210125796","display_name":"University Children's Hospital T\u00fcbingen","ror":"https://ror.org/03esvmb28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118","https://openalex.org/I4210125796"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Anna-Sophia Mast","raw_affiliation_strings":["Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210125796"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054978307","display_name":"Daniel Atar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125796","display_name":"University Children's Hospital T\u00fcbingen","ror":"https://ror.org/03esvmb28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118","https://openalex.org/I4210125796"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Daniel Atar","raw_affiliation_strings":["Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210125796"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093373442","display_name":"Beate Kristmann","orcid":"https://orcid.org/0009-0005-8299-5316","observed_orcids":["https://orcid.org/0009-0005-8299-5316"]},"institutions":[{"id":"https://openalex.org/I4210125796","display_name":"University Children's Hospital T\u00fcbingen","ror":"https://ror.org/03esvmb28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118","https://openalex.org/I4210125796"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Beate Kristmann","raw_affiliation_strings":["Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210125796"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038659706","display_name":"Sophia Scheuermann","orcid":"https://orcid.org/0000-0003-0487-2773","observed_orcids":["https://orcid.org/0000-0003-0487-2773"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]},{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]},{"id":"https://openalex.org/I4210117394","display_name":"Hopp Children's Cancer Center Heidelberg","ror":"https://ror.org/02cypar22","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210117394"]},{"id":"https://openalex.org/I4210125796","display_name":"University Children's Hospital T\u00fcbingen","ror":"https://ror.org/03esvmb28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118","https://openalex.org/I4210125796"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sophia Scheuermann","raw_affiliation_strings":["Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany","Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany","Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Heidelberg, Germany","Hopp Children\u2019s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany","University of Tuebingen, iFIT Cluster of Excellence (EXC 2180) \u201cImage-Guided and Functionally Instructed Tumor Therapies,\u201d Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529"]},{"raw_affiliation_string":"Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210125796"]},{"raw_affiliation_string":"Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Heidelberg, Germany","institution_ids":["https://openalex.org/I2802164966"]},{"raw_affiliation_string":"Hopp Children\u2019s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany","institution_ids":["https://openalex.org/I4210117394"]},{"raw_affiliation_string":"University of Tuebingen, iFIT Cluster of Excellence (EXC 2180) \u201cImage-Guided and Functionally Instructed Tumor Therapies,\u201d Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037246404","display_name":"Christian Martin Seitz","orcid":"https://orcid.org/0000-0002-0520-7866","observed_orcids":["https://orcid.org/0000-0002-0520-7866"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]},{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]},{"id":"https://openalex.org/I4210117394","display_name":"Hopp Children's Cancer Center Heidelberg","ror":"https://ror.org/02cypar22","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210117394"]},{"id":"https://openalex.org/I4210125796","display_name":"University Children's Hospital T\u00fcbingen","ror":"https://ror.org/03esvmb28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118","https://openalex.org/I4210125796"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Christian M. Seitz","raw_affiliation_strings":["Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany","Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany","Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Heidelberg, Germany","Hopp Children\u2019s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529"]},{"raw_affiliation_string":"Department of General Pediatrics, Hematology and Oncology, University Children\u2019s Hospital Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210125796"]},{"raw_affiliation_string":"Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Heidelberg, Germany","institution_ids":["https://openalex.org/I2802164966"]},{"raw_affiliation_string":"Hopp Children\u2019s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany","institution_ids":["https://openalex.org/I4210117394"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5037246404"],"corresponding_institution_ids":["https://openalex.org/I17937529","https://openalex.org/I2802164966","https://openalex.org/I4210117394","https://openalex.org/I4210125796"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antigenic-diversity","display_name":"antigenic diversity","score":0.8669999837875366},{"id":"https://openalex.org/keywords/burkitt-lymphoma","display_name":"Burkitt lymphoma","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.902999997138977},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cd38","display_name":"CD38","score":1.0},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8930000066757202},{"id":"https://openalex.org/keywords/fratricide","display_name":"fratricide","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5703999996185303},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5067999958992004},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.503000020980835},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5004000067710876},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.484499990940094},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4812000095844269},{"id":"https://openalex.org/C159912055","wikidata":"https://www.wikidata.org/wiki/Q14885119","display_name":"CD38","level":4,"score":0.45210000872612},{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.4408000111579895},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.42820000648498535},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3878999948501587},{"id":"https://openalex.org/C204628709","wikidata":"https://www.wikidata.org/wiki/Q864854","display_name":"Biotinylation","level":2,"score":0.3529999852180481},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.3467000126838684},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.33570000529289246},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.33559998869895935},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.3310000002384186},{"id":"https://openalex.org/C2780225316","wikidata":"https://www.wikidata.org/wiki/Q7131441","display_name":"Panobinostat","level":5,"score":0.3206000030040741},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.30959999561309814},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.28439998626708984},{"id":"https://openalex.org/C177284502","wikidata":"https://www.wikidata.org/wiki/Q1005390","display_name":"Adapter (computing)","level":2,"score":0.2824999988079071},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27880001068115234},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.27090001106262207},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.26179999113082886},{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.26030001044273376}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.12.751171","doi":"https://doi.org/10.64898/2026.09.12.751171","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.12.751171","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/18/2026.09.12.751171.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.12.751171","doi":"https://doi.org/10.64898/2026.09.12.751171","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.12.751171","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/18/2026.09.12.751171.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8877140474","display_name":"AdapterCARTZellen zur Therapie der akuten myeloischen Leuk\u00e4mie und leuk\u00e4mischer Stammzellen","funder_award_id":"411791562","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"}],"funders":[{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7213588339.pdf","grobid_xml":"https://content.openalex.org/works/W7213588339.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W2112476236","https://openalex.org/W2179454156","https://openalex.org/W2229483068","https://openalex.org/W2773804840","https://openalex.org/W2787301955","https://openalex.org/W2888063816","https://openalex.org/W2892758519","https://openalex.org/W2903062212","https://openalex.org/W3012942658","https://openalex.org/W3013229857","https://openalex.org/W3108023649","https://openalex.org/W3165250998","https://openalex.org/W3183792933","https://openalex.org/W4205416963","https://openalex.org/W4285040451","https://openalex.org/W4295929648","https://openalex.org/W4297546140","https://openalex.org/W4308545046","https://openalex.org/W4386271804","https://openalex.org/W4388751864","https://openalex.org/W4391990146","https://openalex.org/W4401304720","https://openalex.org/W4401363968","https://openalex.org/W4402586680","https://openalex.org/W4412725572"],"related_works":["https://openalex.org/W4297546140","https://openalex.org/W7124756310","https://openalex.org/W4205416963","https://openalex.org/W4389132025","https://openalex.org/W4401304720","https://openalex.org/W2910362192","https://openalex.org/W6909933351","https://openalex.org/W4415517935","https://openalex.org/W3090025728","https://openalex.org/W2480627035"],"abstract_inverted_index":{"Abstract":[0],"Antigen":[1],"heterogeneity":[2,147],"and":[3,57,85,97,148],"antigen-negative":[4,77],"relapse":[5],"represent":[6],"major":[7],"limitations":[8],"to":[9,34],"durable":[10],"CAR-T":[11,22],"cell":[12,23,67,112,136],"efficacy":[13],"in":[14,73,95,102],"B-lineage":[15],"malignancies.":[16,158],"We":[17],"previously":[18],"developed":[19],"the":[20,74,108,123],"Adapter":[21],"(AdCAR-T)":[24],"platform,":[25],"which":[26],"enables":[27],"flexible":[28,140],"redirection":[29],"of":[30,76,82,107,152],"engineered":[31],"T":[32],"cells":[33],"distinct":[35],"surface":[36],"antigens":[37],"through":[38],"biotinylated":[39],"adapter":[40],"molecules":[41],"(AMs).":[42],"In":[43],"this":[44],"study,":[45],"AMs":[46],"generated":[47],"from":[48],"an":[49,58],"in-house-produced":[50,59],"tafasitamab":[51],"biosimilar":[52,61],"(anti-CD19),":[53],"commercial":[54],"rituximab":[55],"(anti-CD20),":[56],"daratumumab":[60],"(anti-CD38)":[62],"mediated":[63],"potent,":[64],"antigen-specific":[65],"AdCAR-T":[66,111,135],"cytotoxicity.":[68],"While":[69],"single-antigen":[70],"targeting":[71,81,137],"resulted":[72],"selection":[75],"tumor":[78,100],"populations,":[79],"simultaneous":[80],"CD19,":[83],"CD20,":[84],"CD38":[86,109,125],"effectively":[87],"controlled":[88],"a":[89,139],"defined":[90],"heterogeneous":[91],"Burkitt":[92],"lymphoma":[93],"model":[94],"vitro":[96],"induced":[98],"sustained":[99],"control":[101],"vivo":[103],".":[104],"Selective":[105],"loss":[106],"+":[110],"population":[113,127],"after":[114],"CD38-directed":[115],"AM":[116,154],"exposure":[117],"was":[118],"consistent":[119],"with":[120],"fratricide;":[121],"however,":[122],"surviving":[124],"low":[126],"retained":[128],"cytotoxic":[129],"activity.":[130],"These":[131],"findings":[132],"establish":[133],"combinatorial":[134],"as":[138],"pan-B-lineage":[141],"strategy":[142],"for":[143,156],"addressing":[144],"pre-existing":[145],"antigen":[146],"support":[149],"further":[150],"development":[151],"antibody-derived":[153],"combinations":[155],"B-cell":[157]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-19T00:00:00"}